Elevation Total Current Liabilities from 2010 to 2025
| ELEV Stock | USD 0.54 0.05 8.47% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 4.8 M | Current Value 7.9 M | Quarterly Volatility 4.4 M |
Check Elevation Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevation Oncology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.3 K, Interest Expense of 5 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.32. Elevation financial statements analysis is a perfect complement when working with Elevation Oncology Valuation or Volatility modules.
Elevation | Total Current Liabilities |
Latest Elevation Oncology's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Elevation Oncology over the last few years. Total Current Liabilities is an item on Elevation Oncology balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Elevation Oncology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Elevation Oncology's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevation Oncology's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Elevation Total Current Liabilities Regression Statistics
| Arithmetic Mean | 3,379,344 | |
| Geometric Mean | 1,523,500 | |
| Coefficient Of Variation | 130.79 | |
| Mean Deviation | 3,477,930 | |
| Median | 597,000 | |
| Standard Deviation | 4,419,830 | |
| Sample Variance | 19.5T | |
| Range | 15.1M | |
| R-Value | 0.68 | |
| Mean Square Error | 11.3T | |
| R-Squared | 0.46 | |
| Significance | 0 | |
| Slope | 628,302 | |
| Total Sum of Squares | 293T |
Elevation Total Current Liabilities History
About Elevation Oncology Financial Statements
Elevation Oncology investors use historical fundamental indicators, such as Elevation Oncology's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevation Oncology. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 4.8 M | 7.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.